11.07.2015 Views

FINAL PROGRAM - American Society of Gene & Cell Therapy

FINAL PROGRAM - American Society of Gene & Cell Therapy

FINAL PROGRAM - American Society of Gene & Cell Therapy

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

124<strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Gene</strong> & <strong>Cell</strong> <strong>Therapy</strong>Abstract DirectorySaturday, May 22 ndSaturday, May 22, 2010Oral Abstract Session 414Hematologic/Immunologic: Clinical, Preclinical and Safety11:00 AM - 1:00 PMRoom: Maryland Suite612 11:00 AMPolyclonal Reconstitution <strong>of</strong> the Hematopoietic System in TwoPatients <strong>of</strong> a WAS Clinical <strong>Gene</strong> <strong>Therapy</strong> TrialAnna Paruzynski, Kaan Boztug, Claudia Ball, Ali Nowrouzi, Christina Lulay, Marie Böhm,Sonja Naundorf, Klaus Kühlke, Rainer Blasczyk, Irina Kondratenko, Laszló Maródi,Hanno Glimm, Christoph Klein, Christ<strong>of</strong> von Kalle, Manfred Schmidt.613 11:15 AMSustained Partial Phenotypic Correction <strong>of</strong> Hemophilia B in the Dogby a microRNA-Regulated Lentiviral VectorAlessio Cantore, Marco Ranzani, Lucia Sergi Sergi, Giuliana Vallanti, Marina Radrizzani,Brian Brown, Eugenio Montini, Timothy Nichols, Luigi Naldini.614 11:30 AMTiming <strong>of</strong> Anti-T <strong>Cell</strong> Immunosuppressive <strong>Therapy</strong> Is Critical for theSafety <strong>of</strong> Liver Mediated AAV2 Transduction in Rhesus MacaquesJonathan D. Finn, Patricia Favaro, J. Fraser Wright, Federico Mingozzi, Katherine A.High, Valder R. Arruda.615 11:45 AMFactor IX-R338L (FIX Padua) as a Novel Alternative for theTreatment <strong>of</strong> Canine Severe Hemophilia BJonathan D. Finn, Paolo Simioni, Nicholas Iacobelli, Shangzhen Zhou, Timothy C.Nichols, Katherine A. High, Valder R. Arruda.616 12:00 PMErythropoeisis Sustained 1 Year by the EPODURE BioPump inPatients with Chronic Kidney Disease: Further Results <strong>of</strong> Phase I/IIPro<strong>of</strong> <strong>of</strong> Concept TrialBaruch S. Stern, Ehud Shoshani, Andrew L. Pearlman, Philip Ng, Allen R. Nissenson,Eithan Galun, Anatole Besarab, Avi Rimler, Haim Goltzmann, Reem Miari, Alex Okun,Haddas Bookay, Tamar Jibly, Javier A. Abrameto, Michal Elhalel.617 12:15 PMLentiviral <strong>Gene</strong> <strong>Therapy</strong> <strong>of</strong> RAG1 Severe CombinedImmunodeficiency: Risks and Implications for TreatmentNiek P. van Til, Roya Sarwari, Trudi P. Visser, Helen de Boer, Yuedan Li, Julia Hauer,Chantal Lagresle-Peyrou, Olivier Danos, Arnaud Jollet, Fang Zhang, Adrian Thrasher,Barbara Cassani, Monique M. Verstegen, Anna Villa, Marina Cavazzana-Calvo, GerardWagemaker.618 12:30 PMDisruption <strong>of</strong> Glucocorticoid Regulation in Therapeutic Human T <strong>Cell</strong>swith Zinc Finger NucleasesRebecca A. Gardner, Andreas Reik, Carolina Berger, Seitaro Terakura, Philip D. Gregory,Michael C. Jensen, Michael C. Holmes, Stanley R. Riddell.619 12:45 PMLentiviral <strong>Gene</strong> Transfer under Optimized Cytokine ConditionsFacilitates Polyclonal Hematopoiesis <strong>of</strong> Recipient MiceTobias Maetzig, Martijn H. Brugman, Olga S. Kustikova, Zhixiong Li, Melanie Galla, NielsHeinz, Ute Modlich, Bernhard Schiedlmeier, Axel Schambach, Christopher Baum.Oral Abstract Session 415Lung and Respiratory Disease <strong>Gene</strong> & <strong>Cell</strong> <strong>Therapy</strong>11:00 AM - 12:00 PMRoom: Thurgood Marshall W620 11:00 AM<strong>Gene</strong>ration <strong>of</strong> a Transgenic Gut-Corrected CFTR Knockout FerretModel with Intestinal-Specific Expression <strong>of</strong> Ferret CFTRXiaoming Liu, Xingshen Sun, John T. Fisher, Meihui Luo, Hongshu Shui, Ziying Yan,Yaling Yi, Michael J. Goodheart, Gergely Lukacs, David Meyerholz, John F. Engelhardt.621 11:15 AMPersistent Long Term Lentiviral Correction <strong>of</strong> the CFTR <strong>Gene</strong> Defect inCystic Fibrosis MicePatricia Cmielewski, Donald Anson, David W. Parsons.622 11:30 AMDevelopment <strong>of</strong> Optimized hCFTR <strong>Gene</strong> Sequence and ProlongedExpression Vector for Cystic Fibrosis <strong>Therapy</strong>Linas Padegimas, Karla A. Dines, Samuel J. Adams, Sharon M. Oette, Susannah L. Hyatt,Olena Tyr, Christopher R. Gedeon, Ozge Sesenoglu-Laird, Robert C. Moen, Tomasz H.Kowalczyk, Mark J. Cooper.623 11:45 AMExpression <strong>of</strong> Human Alpha-1 Antitrypsin in Mice and Dogs FollowingAAV6 Vector-Mediated <strong>Gene</strong> Transfer to the LungsChristine L. Halbert, David K. Madtes, Andrew E. Vaughan, Zejing Wang, Rainer Storb,Stephen J. Tapscott, A. Dusty Miller.Oral Abstract Session 416<strong>Gene</strong> Regulation12:15 PM - 1:15 PMRoom: Thurgood Marshall W624 12:15 PMEngineered Zinc Finger Transcription Factors for the Treatment <strong>of</strong>Gain <strong>of</strong> Function MutationsClaudio Mussolino, Daniela Sanges, Ciro Bonetti, Elena Marrocco, Umberto Di Vicino,Valeria Marigo, Alberto Auricchio, Germana Meroni, Enrico M. Surace.625 12:30 PMAAV Vectors for Tissue-Specific, Regulated Expression in Heart, Liverand LungShu-Jen Chen, Maria P. Limberis, Lawrence Bish, Ruben Hovhannisyan, Sheena Saighal,Odella Jno-Charles, H. Lee Sweeney, Arbans Sandhu, Julie Johnston, James M. Wilson.EXHIBITOR PROSPECTUSfinal program

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!